Collegium Pharmaceutical Balance Sheet Health
Financial Health criteria checks 3/6
Collegium Pharmaceutical has a total shareholder equity of $195.4M and total debt of $667.2M, which brings its debt-to-equity ratio to 341.4%. Its total assets and total liabilities are $1.1B and $947.9M respectively. Collegium Pharmaceutical's EBIT is $190.6M making its interest coverage ratio 2.8. It has cash and short-term investments of $310.5M.
Key information
341.4%
Debt to equity ratio
US$667.17m
Debt
Interest coverage ratio | 2.8x |
Cash | US$310.55m |
Equity | US$195.43m |
Total liabilities | US$947.88m |
Total assets | US$1.14b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 354's short term assets ($537.6M) exceed its short term liabilities ($457.9M).
Long Term Liabilities: 354's short term assets ($537.6M) exceed its long term liabilities ($490.0M).
Debt to Equity History and Analysis
Debt Level: 354's net debt to equity ratio (182.5%) is considered high.
Reducing Debt: 354's debt to equity ratio has increased from 12.6% to 341.4% over the past 5 years.
Debt Coverage: 354's debt is well covered by operating cash flow (41.2%).
Interest Coverage: 354's interest payments on its debt are not well covered by EBIT (2.8x coverage).